Navigation Links
Breast cancer prevention practices vary across Canada
Date:8/14/2007

Breast cancer preventive practices for Canadian women carrying the cancer gene vary across the country, says University of Toronto research, and many women are not taking advantage of the options available.

The study, published in the journal Open Medicine, followed the experiences of Canadian women with a BRCA1 or BRCA2 mutation a genetic mutation that predisposes them to a 87 per cent lifetime risk of developing breast cancer. Women carrying the gene have several options for cancer prevention including prophylactic surgery, chemoprevention and screening; however, researchers observed significant differences across Canada in the uptake of these preventions, with women in Quebec the least likely to use preventive measures.

We were very surprised by the discrepancy in preventative measures taken across the country, says Professor Kelly Metcalfe, Lawrence Bloomberg Faculty of Nursing, lead author of the study. The benefit of genetic testing is that we can identify women at high risk of developing breast cancer and hopefully reduce that risk. Ultimately though, women have to elect to undertake one of the options.

In the study, 672 Canadian women were identified as carrying the genetic mutation. Followup questionnaires were completed after a mean of four years. Out of the 342 women without breast cancer after four years, 157 (46 per cent) had not undertaken any cancer prevention option such as a mastectomy, oophorectomy or tamoxifen or raloxifene drugs used in chemoprevention. Broken down geographically, 39 per cent of women with the genetic mutation in Ontario did not take preventive measures; 34 per cent in Western Canada and 62 per cent in Quebec.

The numbers show a huge discrepancy, with women in Quebec being the least likely to elect for a preventive option, Metcalfe says. This will have significant implications in terms of the numbers of cancers we see developing in this high-risk group. We still need to do more research to explain why these differences exist.


'/>"/>
Contact: Karen Kelly
k.kelly@utoronto.ca
416-978-5949
University of Toronto
Source:Eurekalert

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Ductal lavage may detect early breast cancer
4. Breast Feeding prevents obesity later on in life
5. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
6. Breast milk is essential
7. Micro-camera provides new breast imaging technique
8. Breast Cancer Surgery Causes Psychological problems
9. Breast cancer evidence
10. Support therapy helps breast cancer patients
11. Letrozole Beats Tamoxifen in Breast Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
(Date:6/24/2016)... ... 2016 , ... Advanced Plastic Surgery Institute ( http://www.advancedplasticsurgeryinstitute.com ), ... official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns the practice, ... says the decision to support the pageant in an official capacity is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois ... are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy ... Gateway Convention Center in Collinsville. , They expect to treat approximately ...
(Date:6/24/2016)... Austin, TX (PRWEB) , ... June 24, 2016 , ... ... laude graduate, joins Evans Dermatology in the South Lamar location as of July 13, ... Texas Southwestern Medical School. As a medical student, she regularly volunteered at the Agape ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: